Publicaciones en las que colabora con Nieves Purificacion Martinez Lago (10)
2022
-
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
PLoS ONE, Vol. 17, Núm. 6 June
-
Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
Scientific Reports, Vol. 12, Núm. 1
2021
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
-
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
BMC Cancer, Vol. 21, Núm. 1
-
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data
Scientific Reports, Vol. 11, Núm. 1
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
2019
-
Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Annals of Oncology, Vol. 30, pp. iv42-iv43
-
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889
-
Is there any affordable and reliable score in local gastric cancer?
Annals of Oncology, Vol. 30, pp. iv60
2018
-
Differences in outcome according to chemotherapy backbone and maintenance treatment in HER2 positive metastatic gastric cancer (GC) or gastroesophageal junction (GEJ)
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii225